Health Care Equipment & Supplies · Nasdaq
PODDInsulet Corp
- Last close
- $152.48 +2.1%
- 52-week range
- $126.40 to $354.88
- Market cap
- $10.6B
- Next earnings
- Not scheduled
Fiscal 2025 at a glance
Revenue
$2.71B
+31% vs FY24
Net income
$247M
-41% vs FY24
Free cash flow
$378M
+24% vs FY24
Net cash
-$233M
Cash $716M, debt $949M
Stock price
Valuation vs its own 10 years
Below its 10-year median on all 4 multiples
Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.
P/E, trailing
25.0x
21.4x4,955x
3rd percentile, below its median of 413x
Positive-earnings quarters only
Price / sales
3.3x
2.8x17.4x
4th percentile, below its median of 8.7x
EV / EBITDA
15.8x
13.6x1,042x
2nd percentile, below its median of 132x
Price / free cash flow
40.7x
34.9x1,774x
20th percentile, below its median of 66.8x
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.
Valuation
- P/E
- 25.0x
- Earnings yield
- 4.0%
- Price / sales
- 3.3x
- Price / book
- 6.7x
- Price / operating cash flow
- 20.8x
- EV / EBITDA
- 15.8x
- EV / sales
- 3.4x
- Free cash flow yield
- 2.5%
Profitability
- Gross margin
- 71.9%
- Operating margin
- 18.4%
- Net margin
- 13.4%
- Return on equity
- 27.2%
- Return on capital
- 18.1%
Growth per year
- Revenue, 3 years
- +27.5%
- Revenue, 5 years
- +24.5%
- Revenue, 9 years
- n/aNot reported
- EPS, 3 years
- +268%
Balance sheet
- Cash and investments
- $584M
- Total debt
- $962M
- Net cash
- -$378M
- Debt / equity
- 0.61x
- Current ratio
- 2.51x
Shares and dividend
- Shares outstanding
- 69.4M
- Share count, 5 years
- +9.0%
- Beta, 1 year
- 0.44
- Dividend yield
- n/a
- Dividend per share, TTM
- n/a
- Payout ratio
- n/a
n/a: No dividend
Ten years of the business
Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.
Fiscal years 2016 to 2025.
Revenue and net incomeLatest quarter $842M
RevenueNet income
Gross profitLatest quarter $632M
EBITDALatest quarter $218M
Margins75 / 23 / 17%
GrossOperatingNet
Earnings per shareLatest quarter $2.03
Cash flowLatest quarter $124M
OperatingCapexFree
Cash vs debtLatest quarter $584M
Cash and investmentsTotal debt
P/E historyNow 25.0x
P/E, median 413x dashed
P/S historyNow 3.3x
P/S, median 8.7x dashed
Revenue and net incomeFY25 $2.71B
RevenueNet income
Gross profitFY25 $1.94B
EBITDAFY25 $564M
Margins72 / 17 / 9%
GrossOperatingNet
Earnings per shareFY25 $3.48
Cash flowFY25 $569M
OperatingCapexFree
Cash vs debtFY25 $716M
Cash and investmentsTotal debt
P/E historyNow 25.0x
P/E, median 413x dashed
P/S historyNow 3.3x
P/S, median 8.7x dashed
Where the revenue comes from
Drug Delivery went from 4% to 1% of revenue in 3 years
Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.
FY22
$1.31B
FY23
$1.70B
FY24
$2.07B
FY25
$2.71B
| Product line | Revenue | Share | vs FY24 |
|---|---|---|---|
| U S Omnipod | $1.92B | 70.9% | +27% |
| International Omnipod | $754M | 27.9% | +44% |
| Drug Delivery | $34.1M | 1.3% | -12% |
Health Care Equipment & Supplies peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | $188B | +10% | 13.8% | 40.4x | 3.9x | 60th percentile |
| DHR Danaher Corp | $164B | +6% | 20.4% | 38.1x | 6.4x | 65th percentile |
| ISRG Intuitive Surgical Inc | $154B | +20% | 28.4% | 53.7x | 13.3x | 48th percentile |
| MDT Medtronic plc | $132B | +10% | 18.1% | 25.3x | 3.5x | 20th percentile |
| SYK Stryker Corp | $118B | +8% | 20.7% | 33.0x | 4.5x | 30th percentile |
| PODD Insulet Corp | $10.6B | +26% | 18.4% | 25.0x | 3.3x | 3rd percentile |
The company
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Headquarters
- Acton, MA
- Fiscal year ends
- December
Around the numbers
What the rest of EdgeStacker knows about PODD.